Todd D. Schell

4.1k total citations · 1 hit paper
97 papers, 3.1k citations indexed

About

Todd D. Schell is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Todd D. Schell has authored 97 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Immunology, 49 papers in Oncology and 26 papers in Molecular Biology. Recurrent topics in Todd D. Schell's work include Immunotherapy and Immune Responses (44 papers), CAR-T cell therapy research (26 papers) and Immune Cell Function and Interaction (25 papers). Todd D. Schell is often cited by papers focused on Immunotherapy and Immune Responses (44 papers), CAR-T cell therapy research (26 papers) and Immune Cell Function and Interaction (25 papers). Todd D. Schell collaborates with scholars based in United States, China and India. Todd D. Schell's co-authors include Satvir S. Tevethia, Lawrence M. Mylin, David F. Claxton, Hong Zheng, Witold B. Rybka, W. Christopher Ehmann, Joseph J. Drabick, Hui Zeng, Liuluan Zhu and Yaxian Kong and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Immunity.

In The Last Decade

Todd D. Schell

92 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor-Specific T Cell Dysfunction Is a Dynamic Antigen-Driven Differentiation Program Initiated Early during Tumorigenesis

2016 484 citations Todd D. Schell et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Todd D. Schell United States	31	1.8k	1.5k	785	248	222	97	3.1k
Robbert M. Spaapen Netherlands	24	1.9k 1.1×	1.8k 1.2×	1.1k 1.4×	230 0.9×	200 0.9×	49	3.4k
Flavio Salazar‐Onfray Chile	34	2.1k 1.2×	1.1k 0.7×	1.1k 1.4×	159 0.6×	232 1.0×	83	3.3k
Michal Baniyash Israel	34	2.9k 1.7×	1.2k 0.8×	1.1k 1.4×	185 0.7×	194 0.9×	62	4.3k
Stefano Ugel Italy	30	3.3k 1.8×	2.1k 1.3×	1.1k 1.4×	216 0.9×	428 1.9×	63	4.6k
Protul Shrikant United States	33	3.2k 1.8×	2.1k 1.4×	1.1k 1.5×	232 0.9×	162 0.7×	47	4.5k
Annalisa Del Prete Italy	31	1.9k 1.1×	849 0.6×	1.0k 1.3×	406 1.6×	255 1.1×	64	3.3k
Vijay Shankaran United States	6	3.0k 1.7×	2.4k 1.5×	949 1.2×	189 0.8×	326 1.5×	7	4.0k
Richard V. Parry United Kingdom	23	3.0k 1.7×	2.2k 1.4×	1.3k 1.6×	290 1.2×	440 2.0×	32	4.6k
Juan Fu United States	18	2.3k 1.3×	1.2k 0.8×	1.2k 1.5×	228 0.9×	481 2.2×	42	3.4k
Paola Larghi Italy	19	1.4k 0.8×	647 0.4×	719 0.9×	139 0.6×	333 1.5×	24	2.3k

Countries citing papers authored by Todd D. Schell

Since Specialization

Citations

This map shows the geographic impact of Todd D. Schell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Todd D. Schell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Todd D. Schell more than expected).

Fields of papers citing papers by Todd D. Schell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Todd D. Schell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Todd D. Schell. The network helps show where Todd D. Schell may publish in the future.

Co-authorship network of co-authors of Todd D. Schell

This figure shows the co-authorship network connecting the top 25 collaborators of Todd D. Schell. A scholar is included among the top collaborators of Todd D. Schell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Todd D. Schell. Todd D. Schell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bollu, Vishnu Sravan, Yu‐Chi Chen, Fan Zhang, et al.. (2025). Managing telomerase and telomere dysfunction in acral melanoma. Pharmacological Research. 215. 107700–107700. 1 indexed citations

Chen, Yu‐Chi, Christopher G. Bazewicz, Saketh S. Dinavahi, et al.. (2024). Emerging Role of the p53 Pathway in Modulating NK Cell–Mediated Immunity. Molecular Cancer Therapeutics. 24(4). 523–535. 2 indexed citations

Chen, Jiaxing, et al.. (2024). Optogenetically engineered Septin-7 enhances immune cell infiltration of tumor spheroids. Proceedings of the National Academy of Sciences. 121(44). e2405717121–e2405717121. 5 indexed citations

Brendle, Sarah A., Vonn Walter, Todd D. Schell, et al.. (2023). Immune Responses in Oral Papillomavirus Clearance in the MmuPV1 Mouse Model. Pathogens. 12(12). 1452–1452. 3 indexed citations

Dhanyamraju, Pavan Kumar, et al.. (2022). Drug-Tolerant Persister Cells in Cancer Therapy Resistance. Cancer Research. 82(14). 2503–2514. 81 indexed citations

Liu, Xiaoming, Carson A. Wills, Longgui Chen, et al.. (2022). Small extracellular vesicles induce resistance to anti-GD2 immunotherapy unveiling tipifarnib as an adjunct to neuroblastoma immunotherapy. Journal for ImmunoTherapy of Cancer. 10(4). e004399–e004399. 34 indexed citations

Jia, Bei, Kevin Rakszawski, David F. Claxton, et al.. (2019). Eomes+T-betlow CD8+ T Cells Are Functionally Impaired and Are Associated with Poor Clinical Outcome in Patients with Acute Myeloid Leukemia. Cancer Research. 79(7). 1635–1645. 48 indexed citations

Li, Guangfu, Dai Liu, Eric T. Kimchi, et al.. (2018). Nanoliposome C6-Ceramide Increases the Anti-tumor Immune Response and Slows Growth of Liver Tumors in Mice. Gastroenterology. 154(4). 1024–1036.e9. 123 indexed citations

Cladel, Nancy M., Lynn R. Budgeon, Karla K. Balogh, et al.. (2017). Mouse papillomavirus infection persists in mucosal tissues of an immunocompetent mouse strain and progresses to cancer. Scientific Reports. 7(1). 16932–16932. 37 indexed citations

10.

Kong, Yaxian, Liuluan Zhu, Todd D. Schell, et al.. (2016). T-Cell Immunoglobulin and ITIM Domain (TIGIT) Associates with CD8+ T-Cell Exhaustion and Poor Clinical Outcome in AML Patients. Clinical Cancer Research. 22(12). 3057–3066. 230 indexed citations

11.

Ward-Kavanagh, Lindsay K., Junjia Zhu, Timothy K. Cooper, & Todd D. Schell. (2014). Whole-Body Irradiation Increases the Magnitude and Persistence of Adoptively Transferred T Cells Associated with Tumor Regression in a Mouse Model of Prostate Cancer. Cancer Immunology Research. 2(8). 777–788. 10 indexed citations

12.

Sagar, Divya, Shet Masih, Todd D. Schell, et al.. (2014). In vivo immunogenicity of Tax(11–19) epitope in HLA-A2/DTR transgenic mice: Implication for dendritic cell-based anti-HTLV-1 vaccine. Vaccine. 32(26). 3274–3284. 14 indexed citations

13.

Hu, Jiafen, Todd D. Schell, Xuwen Peng, Nancy M. Cladel, & Karla K. Balogh. (2010). Using HLA-A2.1 Transgenic Rabbit Model to Screen and Characterize New HLA-A2.1 Restricted Epitope DNA Vaccines. Journal of Vaccines & Vaccination. 1(1). 7 indexed citations

14.

Schell, Todd D.. (2009). A promising natural therapy for equine osteoarthritis.. 28(1). 11–15. 3 indexed citations

15.

Watson, Alan M., et al.. (2008). An SV40 VP1-derived epitope recognized by CD8+ T cells is naturally processed and presented by HLA-A⁎0201 and cross-reactive with human polyomavirus determinants. Virology. 376(1). 183–190. 8 indexed citations

16.

Otáhal, Pavel, et al.. (2006). Early Immunization Induces Persistent Tumor-Infiltrating CD8+ T Cells against an Immunodominant Epitope and Promotes Lifelong Control of Pancreatic Tumor Progression in SV40 Tumor Antigen Transgenic Mice. The Journal of Immunology. 177(5). 3089–3099. 24 indexed citations

17.

Barton, Lance F., Herbert A. Runnels, Todd D. Schell, et al.. (2004). Immune Defects in 28-kDa Proteasome Activator γ-Deficient Mice. The Journal of Immunology. 172(6). 3948–3954. 89 indexed citations

18.

Stanic, Aleksandar K., Rangaiah Shashidharamurthy, Jelena S. Bezbradica, et al.. (2003). Another View of T Cell Antigen Recognition: Cooperative Engagement of Glycolipid Antigens by Va14Ja18 Natural TCR. The Journal of Immunology. 171(9). 4539–4551. 76 indexed citations

19.

Schell, Todd D., John D. Lippolis, & Satvir S. Tevethia. (2001). Cytotoxic T lymphocytes from HLA-A2.1 transgenic mice define a potential human epitope from simian virus 40 large T antigen.. PubMed. 61(3). 873–9. 17 indexed citations

20.

Schell, Todd D. & Satvir S. Tevethia. (2001). Control of Advanced Choroid Plexus Tumors in SV40 T Antigen Transgenic Mice Following Priming of Donor CD8+ T Lymphocytes by the Endogenous Tumor Antigen. The Journal of Immunology. 167(12). 6947–6956. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact